We are working on understanding the immune response against skin cancer to develop new therapies and biomarkers for the benefit of patients.

Our Research

Our group is broadly interested in melanoma epigenetics and with specific interests in identifying epigenetic mechanisms regulating anti tumor immunity and functio. Using mouse models, single cell approaches (scRNA-Seq, ATACseq), genetic perturbation tools (CRISPR) and clinical tissues samples, the group aims to lay the foundation for the next-generation of cancer immunotherapies.

Our Projects

See our ongoing projects.

Our Team

Meet the team.